MMEDMind Medicine (MindMed) Inc.
- PR Newswire
Medtronic Launches Exchange Offer to Complete Separation of MiniMed Group, Inc.
Medtronic plc (Medtronic; NYSE: MDT) today announced that it has commenced an exchange offer to split off at least 80.1% of the shares of MiniMed... ...
- PR Newswire
MiniMed Files Form S-4 Registration Statement in Connection with Medtronic Exchange Offer Announcement
MiniMed (Nasdaq: MMED) announced that it has filed a Form S-4 Registration Statement today with the Securities and Exchange Commission (the "SEC") in ... ...
- Analyst Upgrades
Morgan Stanley Maintains Overweight on Minimed Group, Raises Price Target to $21
Morgan Stanley analyst Kallum Titchmarsh maintains Minimed Group with a Overweight and raises the price target from $19 to $21. ...
- Analyst Upgrades
Citigroup Maintains Buy on Minimed Group, Raises Price Target to $26
Citigroup analyst Joanne Wuensch maintains Minimed Group with a Buy and raises the price target from $23 to $26. ...
- Analyst Upgrades
Evercore ISI Group Maintains Outperform on Minimed Group, Raises Price Target to $27
Evercore ISI Group analyst Daniel Markowitz maintains Minimed Group with a Outperform and raises the price target from $20 to $27. ...
- Analyst Upgrades
Wells Fargo Maintains Overweight on Minimed Group, Raises Price Target to $26
Wells Fargo analyst Larry Biegelsen maintains Minimed Group with a Overweight and raises the price target from $22 to $26. ...
- Analyst Upgrades
These Analysts Boost Their Forecasts On MiniMed Group Following Q1 Sales Results
MiniMed Group beat Q1 sales estimates with 16.6% growth to $843M; shares rose 7.1% as analysts raised price targets to $26-$28. ...
- Analyst Upgrades
UBS Maintains Buy on Minimed Group, Raises Price Target to $28
UBS analyst Patrick Wood maintains Minimed Group with a Buy and raises the price target from $25 to $28. ...
- Analyst Upgrades
Mizuho Maintains Outperform on Minimed Group, Raises Price Target to $26
Mizuho analyst Anthony Petrone maintains Minimed Group with a Outperform and raises the price target from $21 to $26. ...
- Analyst Upgrades
B of A Securities Maintains Buy on Minimed Group, Raises Price Target to $28
B of A Securities analyst Travis Steed maintains Minimed Group with a Buy and raises the price target from $24 to $28. ...
- Analyst Upgrades
BTIG Maintains Buy on Minimed Group, Raises Price Target to $28
BTIG analyst Marie Thibault maintains Minimed Group with a Buy and raises the price target from $25 to $28. ...
- PR Newswire
MiniMed Delivers Strong Start to Fiscal Year 2027 with U.S. Growth Acceleration
MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today reported financial results for its first quarter (Q1) of fiscal year 2027... ...
- PR Newswire
MiniMed to Participate in Upcoming Investor Conferences
MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced that management will participate in fireside chats at the following... ...
- PR Newswire
MiniMed's Smallest App-Controlled Insulin Pump Now Shipping with the World's Smallest Sensor
MiniMed Flex™ with Instinct, made by Abbott, combines discreet design, up to 15 days of sensor wear and proven automation to reduce the work and interruptions of diabetes management NORTHRIDGE, Calif., Aug. 17, 2026 ...
- PR Newswire
MiniMed Flex™ Now Available to Medicare and Medicare Advantage Beneficiaries
MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced that Medicare and Medicare Advantage beneficiaries now have access to ... ...
- PR Newswire
MiniMed to Announce Its Fiscal Year 2027 First Quarter Financial Results
MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced that it expects to report financial results on Tuesday, September 1,... ...
- PR Newswire
MiniMed appoints Alcon CEO David Endicott and Linnea Burman to its Board of Directors
MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced that David Endicott and Linnea Burman have joined its Board of... ...
- PR Newswire
MiniMed launches Instinct sensors in Europe giving people with diabetes more sensor choice with the same proven outcomes
MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced the commercial launch in Europe of both the MiniMed™ 780G system... ...
- PR Newswire
MiniMed's Smallest App-Controlled Insulin Pump is Now Available in the U.S.
MiniMed (Nasdaq: MMED), today announced its first commercial launch of the MiniMed Flex™ system in the United States — its first app-controlled pump... ...
- Analyst Upgrades
Wells Fargo Maintains Overweight on Minimed Group, Lowers Price Target to $22
Wells Fargo analyst Larry Biegelsen maintains Minimed Group with a Overweight and lowers the price target from $26 to $22. ...
- PR Newswire
MiniMed to Expand Sensor Portfolio with Integrated Dual Glucose-Ketone Sensors Made by Abbott
MiniMed (NASDAQ: MMED), a global leader in diabetes technology, today announced an expanded agreement with Abbott to collaborate on commercializing... ...
- PR Newswire
MiniMed Delivers Strong Fourth Quarter and Full Fiscal Year 2026 Financial Results; Provides Fiscal Year 2027 Outlook
MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today reported financial results for its fourth quarter and full fiscal year ended... ...
- PR Newswire
MiniMed to Showcase MiniMed Flex™ and MiniMed Go™ at the American Diabetes Association Scientific Sessions
MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced an overview of its upcoming presence at the American Diabetes... ...
- PR Newswire
MiniMed to Participate in Goldman Sachs 47th Annual Global Healthcare Conference
MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced that management will participate in a fireside chat at the upcoming... ...
- PR Newswire
New Study Showed Consistent Glycemic Outcomes Across Sensors Integrated with MiniMed 780G System
MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced results from a new randomized crossover study demonstrating that... ...